Richard W Pascoe's Net Worth

$828 Thousand

Estimate Recalculated Nov 1, 2024 09:17AM EST

Who is Richard W Pascoe

Richard W Pascoe does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KEMPHARM, INC, Histogen Inc., SEELOS THERAPEUTICS, INC., Pernix Sleep, Inc., and ARIAD PHARMACEUTICALS INC.

SEC CIK

Richard W Pascoe's CIK is 0001343266

Past Insider Trading and Trends

2022 was Richard W Pascoe's most active year for acquiring shares with 9 total transactions. Richard W Pascoe's most active month to acquire stocks was the month of April. 2010 was Richard W Pascoe's most active year for disposing of shares, totalling 12 transactions. Richard W Pascoe's most active month to dispose stocks was the month of February. 2010 saw Richard W Pascoe paying a total of $233,700.00 for 440,000 shares, this is the most they've acquired in one year. In 2010 Richard W Pascoe cashed out on 410,291 shares for a total of $1,010,817.80, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KEMPHARM, INC

Chief Executive Officer
Updated Mar 13, 2023
Form 4
50.07%
10.00K
$4.20
$41.98K
Mar 13, 2023
29.97K
Purchase
Mar 09
Form 4
90.71%
9.50K
$5.44
$51.68K
Jan 13, 2023
19.97K
Purchase
Jan 13
Form 4
700.00K
Jan 11, 2023
700.00K
Grant
Jan 09
Form 4
152.21%
5.00K
$4.92
$24.61K
May 18, 2022
8.29K
Purchase
May 18
Form 4
127.29K
Feb 03, 2022
127.29K
Grant
Feb 01
Form 4
84.03%
1.50K
$7.88
$11.82K
Nov 30, 2021
3.29K
Purchase
Nov 30
Form 4
100.00K
Nov 10, 2021
100.00K
Grant
Nov 10
Form 4
15.00K
Jun 21, 2021
15.00K
Grant
Jun 17
Form 4
53.84%
10.00K
$0.64
$6.35K
Aug 18, 2020
28.57K
Purchase
Aug 18
Form 4
30.00K
Jun 22, 2020
30.00K
Grant
Jun 19
Form 4
92.57%
8.93K
Jul 02, 2019
18.57K
Grant
Jun 30
Form 4
9.64K
May 14, 2019
9.65K
Grant
May 10
Form 4
30.00K
Apr 26, 2019
30.00K
Grant
Apr 24
Form 4
15.00K
May 24, 2018
15.00K
Grant
May 22
Form 4
10.00K
May 24, 2017
10.00K
Grant
May 23
Form 4
10.00K
May 26, 2016
10.00K
Grant
May 24
Form 4
10.00K
Aug 27, 2015
10.00K
Grant
Aug 25
Form 3
Apr 15, 2015
Showing 18 results

Histogen Inc.

See Remarks
Updated May 28, 2020
Form 3
May 28, 2020
Showing 1 results

SEELOS THERAPEUTICS, INC.

CEO & Secretary
Updated Jan 08, 2024
Form 4
1.67K
Jan 08, 2024
1.67K
Grant
Jan 04
Form 4
50.00K
Jan 05, 2023
50.00K
Grant
Jan 05
Form 4
35.00K
Jan 06, 2022
35.00K
Grant
Jan 05
Form 4
16.00K
Jan 08, 2021
16.00K
Grant
Jan 06
Form 4
16.00K
Jan 07, 2020
16.00K
Grant
Jan 06
Form 4
16.00K
Mar 21, 2019
16.00K
Grant
Mar 20
Form 4
-22.38%
-44.81K
$0.23
-$10.15K
Jan 24, 2019
155.40K
Tax
Jan 23
Form 4
-7.95%
-17.29K
$0.31
-$5.29K
Nov 30, 2018
200.21K
Tax
Nov 30
Form 4
105.39%
237.32K
$1.84
-$14.13K
Jan 03, 2018
462.50K
Grant
Jan 01 - Jan 03
Form 4
-7.70%
-18.79K
$1.56
-$29.31K
Sep 07, 2017
225.18K
Tax
Sep 05
Form 4
69.46%
100.00K
Jun 05, 2017
243.97K
Grant
Jun 01
Form 4
-2.51%
-3.71K
$2.78
-$10.32K
Mar 24, 2017
143.97K
Tax
Feb 15
Form 4
209.74%
100.00K
Jan 06, 2017
147.68K
Grant
Jan 05
Form 4
276.07%
350.00K
Apr 27, 2016
476.78K
Grant
Apr 25
Form 4
1,233.57%
579.78K
Mar 17, 2016
626.78K
Grant
Mar 15
Form 4
450.00K
Jan 30, 2015
150.00K
Grant
Jan 29
Form 4
27.03%
10.00K
$1.02
$10.22K
Dec 22, 2014
47.00K
Purchase
Dec 22
Form 4
48.00%
12.00K
$1.51
$18.12K
Oct 24, 2014
37.00K
Purchase
Oct 22
Form 4
177.50K
Feb 24, 2014
177.50K
Grant
Feb 20
Form 4
422.31%
147.81K
Feb 10, 2014
182.81K
Grant
Dec 30 - Feb 06
Form 4
70.00K
$2.85
$199.50K
May 24, 2013
70.00K
Purchase
May 23
Form 3
Mar 20, 2013
Showing 22 results

Pernix Sleep, Inc.

President and CEO
Updated Mar 08, 2013
Form 4
-100.00%
-98.29K
Mar 08, 2013
Disposition
Mar 06
Form 4
7.30%
7.14K
Jan 03, 2013
104.93K
Grant
Dec 31
Form 4
92.53%
50.00K
Nov 20, 2012
104.04K
Grant
Nov 16
Form 4
24.46%
75.12K
Oct 02, 2012
382.28K
Grant
Sep 30
Form 4
33.13%
76.44K
Jul 03, 2012
307.16K
Grant
Jul 02
Form 4
-7.52%
-18.75K
$0.48
-$8.94K
Jan 04, 2012
230.73K
Sale
ScheduledJan 03
Form 4
5.64%
11.10K
$2.25
$24.94K
Jun 13, 2011
207.81K
Purchase
Jun 10
Form 4
522.95%
375.00K
Mar 09, 2011
446.71K
Grant
Mar 07
Form 4
-16.12%
-13.78K
$2.68
-$36.98K
Dec 03, 2010
71.71K
Sale
ScheduledDec 01
Form 4
1,613.94%
250.00K
Apr 05, 2010
265.49K
Grant
Apr 01
Form 4
-39.69%
-104.51K
$3.61
-$502.72K
Mar 19, 2010
158.82K
Sale
ScheduledMar 18
Form 4
-14.12%
-40.00K
$2.62
-$111.32K
Mar 03, 2010
243.33K
Sale
ScheduledMar 01
Form 4
-15.68%
-62.00K
$2.13
-$126.10K
Feb 09, 2010
333.33K
Sale
ScheduledFeb 05
Form 4
-13.33%
-8.00K
$1.07
-$8.55K
Jan 05, 2010
52.00K
Sale
ScheduledDec 31
Form 4
150.00K
Jul 20, 2009
150.00K
Grant
Jul 16
Form 4
-33.33%
-216.67K
Jun 10, 2009
433.33K
Disposition
Jun 09
Form 4
326.45%
195.87K
Feb 19, 2009
255.87K
Grant
Feb 17
Form 4
60.00K
Dec 02, 2008
60.00K
Grant
Nov 28
Form 4/A
500.00K
Aug 13, 2008
500.00K
Grant
Aug 11
Form 4
500.00K
Aug 13, 2008
50.00K
Grant
Aug 11
Form 3
Aug 13, 2008
Showing 21 results

ARIAD PHARMACEUTICALS INC

Senior VP, COO
Updated Apr 15, 2008
Form 4
61.00K
Apr 15, 2008
61.00K
Grant
Apr 11
Form 4
25.00K
Jul 02, 2007
25.00K
Grant
Jun 28
Form 4
80.00K
Apr 18, 2007
80.00K
Grant
Apr 16
Form 4
75.00K
Dec 16, 2005
75.00K
Grant
Dec 13
Form 3
Nov 08, 2005
Showing 5 results